Literature DB >> 5330184

Immunological studies in ulcerative colitis. 3. Incidence of antibodies to colon-antigen in ulcerative colitis and other gastro-intestinal diseases.

R Lagercrantz, S Hammarström, P Perlmann, B E Gustafsson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5330184      PMCID: PMC1579200     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  16 in total

1.  Incidence of haemagglutinating and complement-fixing antibodies.

Authors:  G L ASHERSON; O BROBERGER
Journal:  Br Med J       Date:  1961-05-20

2.  Lightweight stainless steel systems for rearing germfree animals.

Authors:  B E GUSTAFSSON
Journal:  Ann N Y Acad Sci       Date:  1959-05-08       Impact factor: 5.691

3.  [Research on the anticolon autoantibodies during hemorrhagic rectocolitis and various digestive diseases].

Authors:  Z MARATKA; V WAGNER
Journal:  Rev Fr Etud Clin Biol       Date:  1961-02

4.  Auto-immune reactions in the course of ulcerative colitis.

Authors:  J POLCAK; V VOKURKA
Journal:  Am J Dig Dis       Date:  1960-05

5.  [Colitis ulcerosa].

Authors:  T ALM; B IHRE
Journal:  Nord Med       Date:  1958-04-17

6.  Ultra-rapid fluorescent labelling of proteins.

Authors:  H RINDERKNECHT
Journal:  Nature       Date:  1962-01-13       Impact factor: 49.962

7.  Antigen from colon of germfree rats and antibodies in human ulcerative colitis.

Authors:  P Perlmann; S Hammarström; R Lagercrantz; B E Gustafsson
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

8.  Autoimmunity in pernicious anemia and thyroiditis: a family study.

Authors:  D Doniach; I M Roitt; K B Taylor
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

9.  An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area.

Authors:  J G Evans; E D Acheson
Journal:  Gut       Date:  1965-08       Impact factor: 23.059

10.  Demonstration of an epithelial antigen in colon by means of fluorescent antibodies from children with ulcerative colitis.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

View more
  34 in total

1.  Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part II.

Authors:  R G Shorter; D A Shephard
Journal:  Am J Dig Dis       Date:  1975-07

2.  C3 metabolism in ulcerative colitis and Crohn's disease.

Authors:  H J Hodgson; B J Potter; D P Jewell
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

3.  In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis.

Authors:  T Hibi; M Ohara; K Toda; A Hara; H Ogata; Y Iwao; N Watanabe; M Watanabe; Y Hamada; K Kobayashi
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

4.  Autoantibodies in ulcerative colitis.

Authors:  A R McGiven; T Ghose; R C Nairn
Journal:  Br Med J       Date:  1967-04-01

5.  A clinico-immunological study of ulcerative colitis and ulcerative proctitis.

Authors:  A H Smith; I W Macphee
Journal:  Gut       Date:  1971-01       Impact factor: 23.059

Review 6.  Alterations in immunologic mechanisms in diseases of the gastrointestinal tract.

Authors:  A L Ginsberg
Journal:  Am J Dig Dis       Date:  1971-01

7.  Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis.

Authors:  F Takahashi; K M Das
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  The humoral immune system in inflammatory bowel disease. II. Immunologlobulin levels.

Authors:  H J Hodgson; D P Jewell
Journal:  Am J Dig Dis       Date:  1978-02

9.  Circulating lipid A antibodies despite absence of systemic endotoxemia in patients with Crohn's disease.

Authors:  W Kruis; P Schussler; M Weinzierl; C Galanos; J Eisenburg
Journal:  Dig Dis Sci       Date:  1984-06       Impact factor: 3.199

10.  Cellular hypersensitivity to components of intestinal mucosa in ulcerative colitis and Crohn's disease.

Authors:  G Bendixen
Journal:  Gut       Date:  1969-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.